查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1990191

動物源性特種配料市場：依產品類型、動物來源、應用、通路與形態分類－2026-2032年全球市場預測

Animal-derived Specialty Ingredients Market by Product Type, Animal Source, Application, Distribution Channel, Form - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025年動物性特殊配料市場價值為1,173.5億美元，預計到2026年將成長至1,241.1億美元，複合年成長率為6.03%，到2032年將達到1,768.5億美元。

主要市場統計數據
基準年 2025 1173.5億美元
預計年份：2026年 1241.1億美元
預測年份 2032 1768.5億美元
複合年成長率 (%) 6.03%

對推動動物源特種原料生態系統重組的結構、技術和相關人員期望進行了深入的概述。

動物性特殊原料產業處於傳統與高科技創新交會的十字路口，這裡傳承數百年的原料與現代製藥科學和嚴格的監管法規相互交融。近年來，價值鏈上的各公司都被迫重新思考其採購模式，加強可追溯性和品管，並採用新的加工技術，以滿足化妝品、營養保健品、診斷試劑、食品和藥品應用領域不斷變化的性能要求。本文總結了對於希望在這個複雜的生態系統中尋求明確方向的高階主管、採購經理、產品開發人員和監管回應團隊至關重要的核心結構動態。

監管日益嚴格、對原產地資訊的需求不斷成長以及技術進步如何重塑供應鏈，並促進該行業原料層面的差異化。

由於法規不斷演變、終端用戶期望不斷提高以及技術日趨成熟等因素的共同作用，動物源性特種配料產業格局正在改變。產業相關人員被迫遵守日益嚴格的可追溯性要求和認證，這促使他們增加對數位化文件、供應商審核以及從實驗室到市場的檢驗通訊協定的投資。因此，價值標準正從單純的價格競爭轉向可驗證的來源和品質保證，而那些能夠實現嚴格的供應鏈透明度的企業將從中受益。

本研究分析了供應鏈必須如何應對和適應策略採購，以應對預計到 2025 年的關稅變化和跨境貿易壓力。

2025年關稅政策變化帶來的累積影響，進一步加劇了採購和貿易特種動物性原料企業的經營複雜性。關稅調整擴大了區域成本差距，促使企業重新評估供應商網路和運輸方式。一些製造商的因應措施包括：將採購重心轉移到貿易協定較有利的地區，或透過減少策略供應商數量來整合採購量，從而維持談判優勢。這種重新分配通常涉及營運方面的選擇，例如增加國內庫存緩衝或提前協商包含價格和交貨承諾的長期合約。

透過對產品規格、動物來源、最終用途需求、通路和物理形態進行清晰的細分分析，可以指導優先排序和投資決策。

精準的市場區隔對於確定投資優先順序和最佳化打入市場策略至關重要。按產品類型分類，業界關注的焦點集中在硫酸軟骨素、膠原蛋白胜肽、明膠、角質蛋白和羊毛脂。此外，膠原蛋白胜肽可細分為高、低、中分子量三種類型，而明膠則依其飽和度分為高、低、中三種。這些細分市場會影響最終應用領域的配方選擇、功能性和法規遵循。依動物來源分類，牛、海鮮、豬或禽類來源的產品也有差異。每種來源在致敏性、永續性認知和監管審查方面都具有獨特的特性，從而影響消費者在化妝品和藥品等敏感應用領域的接受度。按應用領域分類，飼料、化妝品和個人護理、診斷、食品和飲料、營養保健品和膳食補充劑以及藥品等領域的需求模式各不相同，每種應用領域都有其自身的純度、可追溯性和性能標準，供應商必須滿足這些標準才能符合規範要求。根據分銷管道的不同，客戶的供應途徑包括直銷、批發商、電商和零售商，不同通路對經濟效益和服務方面的期望差異顯著，因此需要開發客製化的商業模式。根據產品形態的不同，顆粒、液體和粉末的分類會影響下游生產商的處理、保存期限、劑量精度和配方流程。

細微的區域監管差異、物流能力和永續性預期如何影響全球市場的採購選擇和商業性機會？

區域趨勢持續影響企業的競爭定位和策略規劃。在美洲，供應商生態系統受益接近性大規模終端消費市場以及完善的低溫運輸和物流基礎設施，從而縮短了配方主導產品的上市週期。該地區的監管要求通常側重於產品安全性和可追溯性，當地企業正投資於完善的文件管理系統和供應商審核，以確保下游合作夥伴的權益。這種區域環境也推動了對用於化妝品、營養保健品和藥品的高性能原料的需求。

深入了解策略投資、垂直整合和認證主導的差異化如何決定供應商實力和長期商業性韌性。

競爭格局由成熟的原料生產商、專業加工商和垂直整合型企業組成，這些企業掌控著從原料採購到高純度加工的整個價值鏈。主要企業透過投資先進的分餾技術、完善的品管系統和可驗證的可追溯性計劃來脫穎而出，從而解決客戶對安全性、來源和永續性的擔憂。加工商與下游製劑生產商之間的夥伴關係日益普遍，這使得雙方能夠共同開發特定應用等級的產品，並加速創新產品的上市速度。

可操作的企業優先事項，以增強韌性，實現高階定位，並使經營模式適應特定應用的客戶期望。

產業領導企業應優先致力於增強供應鏈韌性、提升產品差異化並深化客戶夥伴關係。透過多元化的供應鏈和檢驗的可追溯性項目來強化供應商生態系統，可以降低單一來源衝擊帶來的風險，並提升議價能力。投資於加工能力，以實現客製化的分子譜和特定的花色強度，將有助於在化妝品、營養保健品和製藥應用領域獲得高階定位，因為在這些領域，規格比商品價格更為重要。

嚴謹的、以實踐者為中心的研究途徑，結合專家訪談、文件分析和情境檢驗，確保獲得可操作和檢驗的見解。

本報告整合了透過結構化研究途徑獲得的定性和定量資訊，旨在確保其準確反映行業實際情況和相關人員的觀點。主要研究包括對原料製造商、配方開發公司、經銷商和終端用戶組織的採購經理、研發科學家、法規專家和銷售主管進行結構化訪談，從而深入了解採購趨勢、品質要求和特定應用領域的優先事項。次要研究則涉及對公開的監管指南、貿易政策公告、行業技術文獻和企業資訊披露的審查，以闡明營運和合規趨勢的背景。

最終將策略挑戰和營運行動整合起來，將分析見解轉化為整個價值鏈上的永續競爭優勢。

總而言之，動物性特殊食材的市場格局正受到多種因素的共同影響而重塑，這些因素包括監管預期、消費者和買家對產品來源的要求，以及技術進步帶來的更精準的配料規格客製化。這些因素有利於那些能夠將卓越的技術加工能力、可驗證的供應鏈透明度和靈活的商業模式結合的公司。細微的區域監管差異、貿易趨勢和應用層面的要求相互交織，使得統一的策略難以獲得持續的競爭優勢。相反，針對特定應用和分銷管道進行有針對性的投資，更有可能帶來最永續的回報。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：動物源性特種配料市場：依產品類型分類

  • 硫酸軟骨素
  • 膠原蛋白肽
  • 明膠
  • 角蛋白
  • 羊毛脂

第9章：以動物來源分類的特種配料市場

  • 牛
  • 漁業
  • 豬
  • 家禽

第10章：動物源特種配料市場：依應用領域分類

  • 飼料
  • 化妝品和個人護理
  • 診斷
  • 食品/飲料
  • 營養保健品
  • 製藥

第11章：動物源特種配料市場：依分銷管道分類

  • 線上
  • 離線

第12章：動物源特種配料市場：依形式分類

  • 顆粒
  • 液體
  • 粉末

第13章：動物源特種配料市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：動物性特種配料市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：動物源性特種配料市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國動物源特種配料市場

第17章：中國動物源性特種配料市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AMCO Proteins
  • Archer Daniels Midland Company
  • Arla Foods Ingredients Group P/S
  • Associated British Foods PLC
  • Cooke Inc.
  • Dairy Farmers of America, Inc.
  • Darling Ingredients Inc.
  • DuPont de Nemours, Inc.
  • Fonterra Co-operative Group Limited
  • Gelita AG
  • Imperial-Oel-Import Handelsgesellschaft mbH
  • Kemin Industries, Inc.
  • Kerry Group PLC
  • Lacto Japan Co., Ltd.
  • NCC Food Ingredients
  • Novo Holdings A/S
  • Oceana Group
  • Royal FrieslandCampina NV
  • Sanimax ABP Inc.
  • Tessenderlo Group
  • The Kraft Heinz Company
  • Nitta Gelatin NA Inc.
Product Code: MRR-7949F0583A40

The Animal-derived Specialty Ingredients Market was valued at USD 117.35 billion in 2025 and is projected to grow to USD 124.11 billion in 2026, with a CAGR of 6.03%, reaching USD 176.85 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 117.35 billion
Estimated Year [2026] USD 124.11 billion
Forecast Year [2032] USD 176.85 billion
CAGR (%) 6.03%

An illuminating orientation to the structural drivers, technological enablers, and stakeholder expectations reshaping the animal-derived specialty ingredients ecosystem

The animal-derived specialty ingredients domain sits at the crossroads of tradition and high-technology innovation, where centuries-old raw materials intersect with modern formulation science and regulatory scrutiny. Over recent years, companies across the value chain have been compelled to rethink sourcing paradigms, elevate traceability and quality controls, and adopt novel processing techniques to meet evolving performance expectations in cosmetics, nutraceuticals, diagnostics, food, and pharmaceutical applications. This introduction distills the core structural dynamics that matter to executives, procurement leads, product developers, and regulatory affairs teams seeking clarity in a complex ecosystem.

Transitioning from legacy supply arrangements toward resilient, transparent supply chains has become a strategic imperative rather than a compliance nicety. At the same time, technological advances in fractionation, enzymatic hydrolysis, and purification have expanded the functional and application-specific capabilities of ingredients such as collagen peptides, chondroitin sulfate, gelatin, keratin, and lanolin. Converging trends around sustainability, animal welfare, and consumer-driven transparency are re-shaping market expectations and compelling firms to invest in verifiable sourcing and processing innovations.

This section frames the critical levers-product differentiation, source diversity, application tailoring, and distribution architecture-that undergird competitive positioning. By setting context on these core themes, readers can better evaluate strategic trade-offs and prioritize initiatives that balance cost, compliance, and innovation while preserving access to key end markets.

How regulatory rigor, provenance demand, and technological advances are jointly reconfiguring supply chains and elevating ingredient-tier differentiation in the sector

The landscape for animal-derived specialty ingredients is undergoing transformative shifts driven by interplay between regulatory evolution, heightened end-customer expectations, and technological maturation. Industry participants are responding to more rigorous traceability mandates and certifications, which in turn compel investments in digital documentation, supplier audits, and lab-to-market verification protocols. This moves value away from purely price-based competition toward demonstrable provenance and quality assurance, benefiting firms that can operationalize rigorous supply-chain transparency.

Parallel to regulatory and transparency pressures, product innovation is accelerating. Advances in fractionation and molecular characterization enable producers to deliver tailored collagen fractions, gelatin of specific bloom strengths, and keratin preparations optimized for hair and skin performance. These technical capabilities facilitate the development of higher-value applications in cosmetics, nutraceuticals, and diagnostics, elevating ingredient specifications as a source of differentiation. At the same time, sustainability and animal welfare considerations have pushed both upstream sourcing strategies and downstream product claims, prompting some manufacturers to integrate third-party auditing and to explore blended sourcing models that mix bovine, marine, porcine, and poultry inputs to balance performance and perception.

Finally, distribution and commercial models are adapting; direct-to-formulator engagements and e-commerce-enabled sample logistics are increasingly important complements to traditional distributor networks. Together, these shifts are creating windows of opportunity for firms that combine technical excellence with trusted supply practices, and they are raising the bar for incumbents that rely on cost-only positioning.

Analyzing the systemic supply chain responses and strategic sourcing adaptations prompted by tariff shifts and cross-border trade pressures in 2025

The cumulative effects of tariff policy changes in 2025 introduced an additional layer of complexity for companies sourcing and trading animal-derived specialty ingredients. Tariff adjustments amplified cost differentials across origin geographies, prompting a reassessment of supplier networks and transportation modalities. Some manufacturers responded by reallocating sourcing toward regions with more favorable trade arrangements or by consolidating volumes with fewer strategic suppliers to preserve negotiating leverage. This recalibration was often accompanied by operational choices to increase onshore inventory buffers and to pre-negotiate term agreements that lock in price and delivery commitments.

Importantly, tariff shifts accelerated conversations about nearshoring and vertical integration as pathways to reduce exposure to border cost volatility. Firms that maintained diversified supplier bases and invested in agile logistics saw better capacity to absorb short-term cost shocks without disrupting customer obligations. Meanwhile, companies dependent on single-origin feeds encountered pressure to justify premium positioning or to absorb margin compression. The net result has been stronger emphasis on contractual flexibility, scenario planning, and hedging of non-price risks such as regulatory hold-ups and inspection delays.

Across applications, downstream customers signaled varying tolerance for passing through cost increases. Partners in high-value segments such as pharmaceuticals and diagnostics were more amenable to absorbing incremental costs for assured quality and compliance, while lower-margin channels such as conventional animal feed exerted greater price sensitivity. This divergence reinforced the strategic importance of product premiumization, formulation value-adds, and longer-term commercial partnerships as means to preserve margin and continuity of supply in a tariff-volatile environment.

Clear segmentation intelligence across product specifications, animal origin, end-use demands, distribution pathways, and physical form to guide prioritization and investment choices

A precise understanding of segmentation is essential for prioritizing investments and tailoring go-to-market approaches. Based on product type, industry attention centers on Chondroitin Sulfate, Collagen Peptides, Gelatin, Keratin, and Lanolin, with further granularity in Collagen Peptides segmented into High Molecular Weight, Low Molecular Weight, and Medium Molecular Weight variants, and Gelatin evaluated across High Bloom, Low Bloom, and Medium Bloom classifications; these sub-segments drive formulation choices, functionality and regulatory handling across end uses. Based on animal source, differentiation arises from Bovine, Marine, Porcine, and Poultry origins, each bringing distinct attributes for allergenicity, sustainability perceptions, and regulatory scrutiny which influence customer acceptance in sensitive applications such as cosmetics and pharmaceuticals. Based on application, demand patterns diverge across Animal Feed, Cosmetics & Personal Care, Diagnostics, Food & Beverages, Nutraceuticals & Supplements, and Pharmaceuticals, with each application imposing unique purity, traceability, and performance thresholds that suppliers must meet to win specifications. Based on distribution channel, route-to-customer is practiced through Direct Sales, Distributors, E-Commerce, and Retailers, where channel economics and service expectations differ materially and necessitate tailored commercial models. Based on form, product differentiation into Granules, Liquid, and Powder formats affects handling, shelf life, dosing accuracy, and formulation workflows for downstream manufacturers.

This segmentation profile should guide strategic choices: investments in molecular-specific processing capabilities will favor premium collagen fractions and high-bloom gelatins for technical formulations, while broadening animal-source options can mitigate single-origin exposure and unlock new regional markets. Channel strategy must align with customer service models-direct sales and e-commerce excel at specification-driven, small-batch engagements, whereas distributors and retailers support scale-oriented rollouts. Ultimately, the intersection of product-type nuance, animal-source attributes, application-specific requirements, channel economics, and physical form dictates where margin pools and competitive advantage will materialize.

How regional regulatory nuance, logistics capability, and sustainability expectations shape sourcing choices and commercial opportunities across global markets

Regional dynamics continue to shape competitive positioning and strategic planning. In the Americas, supplier ecosystems benefit from proximity to large end-use markets and well-established cold chain and logistics infrastructure, which supports quicker commercialization cycles for formulation-driven products. Regulatory expectations in this region often emphasize product safety and traceability, leading local players to invest in robust documentation systems and supplier audits that reassure downstream partners. This regional context also fosters demand for high-performance ingredient grades that serve cosmetics, nutraceuticals, and pharmaceutical applications.

In Europe, Middle East & Africa, the regulatory environment is characterized by stringent standards and growing attention to sustainability and animal welfare, prompting firms to secure certifications and to demonstrate ethical sourcing practices. This region's customers often prioritize provenance and environmental credentials alongside technical performance, creating opportunities for suppliers that can verify low-impact harvest and processing methods. Commercial networks in this region can be complex and typically reward partners who can navigate cross-border compliance and multi-tier distribution challenges.

The Asia-Pacific region combines rapid demand growth with diverse sourcing bases and a strong manufacturing presence for intermediate processing. Many producers in this region are integrating advanced processing capabilities at scale, supplying both regional and global customers. Price sensitivity varies by application, with higher-value segments accepting stricter quality demands in exchange for reliability and formulation performance. Across regions, firms that align sourcing, certification, and customer-service models to regional expectations are better positioned to capture preferential commercial terms and long-term partnerships.

Insight into how strategic investments, vertical moves, and certification-driven differentiation determine supplier strength and long-term commercial resilience

The competitive landscape blends established ingredient manufacturers, specialist processors, and vertically integrated players that control segments of the value chain from raw material procurement through high-purity processing. Leading firms differentiate through investments in advanced fractionation, consistent quality management systems, and demonstrable traceability programs that address customer concerns around safety, provenance, and sustainability. Partnerships between processors and downstream formulators are increasingly common, enabling co-development of application-specific grades and shortening time-to-market for innovations.

Strategic behaviors among key companies include consolidation to secure raw material streams, targeted acquisitions to add complementary processing capabilities, and joint ventures to enter new geographic markets with reduced entry risk. A premium is placed on certifications and independent auditability, which serve as a proxy for reliability and can open doors to regulated end markets. Smaller and more agile niche players compete by serving specialized application needs, offering customized molecular fractions, bloom strengths, or formats that larger producers may not prioritize.

Market leaders that pair technical excellence with commercial responsiveness tend to secure long-term supply contracts and preferred-supplier status with high-value customers. Conversely, companies that underinvest in traceability, compliance, or processing differentiation face pressure to compete harder on price and may be more vulnerable to margin erosion during periods of raw-material volatility or policy-driven cost shocks.

Actionable corporate priorities that strengthen resilience, unlock premium positioning, and align commercial models to application-specific customer expectations

Industry leaders should prioritize actions that reinforce supply resilience, elevate product differentiation, and deepen customer partnerships. Strengthening supplier ecosystems through multi-source arrangements and verified traceability programs reduces exposure to single-origin shocks and improves negotiating leverage. Investing in processing capabilities that deliver tailored molecular profiles or specific bloom strengths will enable premium positioning in cosmetics, nutraceutical, and pharmaceutical applications where specification matters more than commodity pricing.

Commercial strategies should emphasize co-development with formulators and longer-term contractual arrangements that align incentives across the value chain. These partnerships can accelerate product innovation while providing predictable demand signals that justify capital investments. In parallel, companies should refine channel strategies by matching distribution models-direct sales, distributors, e-commerce, retailers-to customer segments' service and sample needs, thereby optimizing cost-to-serve while preserving growth avenues.

Finally, corporate sustainability and governance actions must be operationalized. Transparent animal welfare protocols, third-party audits, and sustainability metrics not only satisfy regulatory and customer demands but also serve as differentiators in crowded product categories. Executing on these recommendations will require cross-functional alignment among procurement, R&D, quality, and commercial teams to convert strategic intent into measurable outcomes.

A rigorous, practitioner-focused research approach combining expert interviews, document analysis, and scenario validation to ensure actionable and verifiable findings

This report synthesizes qualitative and quantitative inputs drawn from a structured research approach designed to ensure fidelity to industry realities and stakeholder perspectives. Primary research included structured interviews with procurement leaders, R&D scientists, regulatory specialists, and commercial executives across ingredient producers, formulators, distributors, and end-user organizations; these conversations informed insights into sourcing dynamics, quality requirements, and application-specific priorities. Secondary research encompassed a careful review of public regulatory guidance, trade policy notices, industry technical literature, and company disclosures to contextualize operational and compliance trends.

Analytical rigor was applied through triangulation: insights from expert interviews were cross-validated with supply-chain documentation, processing capability disclosures, and observable commercial behaviors such as contract structures and channel selection. Where appropriate, scenario analysis was used to explore sensitivity to trade policy shifts and supply disruptions, focusing on operational levers rather than market forecasting. Quality assurance included peer review by subject-matter experts to ensure technical accuracy and to surface potential blind spots related to animal-source attributes, processing technologies, and application constraints.

This methodology provides a robust foundation for strategic decision-making by blending practitioner insight with documentary evidence and technical validation, all while emphasizing transparency and reproducibility of core findings and recommendations.

Final synthesis of strategic imperatives and operational actions that translate analytical insight into durable competitive advantage across the value chain

In summary, the animal-derived specialty ingredients landscape is being reshaped by a convergence of regulatory expectations, consumer and buyer demands for provenance, and technological advances that enable more precisely tailored ingredient specifications. These forces favor businesses that can combine technical processing excellence with demonstrable supply-chain transparency and flexible commercial models. The interplay of regional regulatory nuance, trade dynamics, and application-level requirements means that one-size-fits-all strategies are unlikely to deliver consistent advantage; instead, selective investment aligned to target applications and channels will generate the most durable returns.

As supply chain and policy uncertainties persist, firms that proactively diversify supplier bases, invest in certification and traceability, and pursue co-development partnerships with downstream customers will be better positioned to capture higher-value opportunities. Implementation of these strategies requires cross-functional coordination and disciplined execution, but the payoff lies in enhanced resilience, improved margin retention, and strengthened customer relationships. The conclusion underscores the importance of translating analytical insight into concrete operational changes that are measurable and repeatable.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Animal-derived Specialty Ingredients Market, by Product Type

  • 8.1. Chondroitin Sulfate
  • 8.2. Collagen Peptides
  • 8.3. Gelatin
  • 8.4. Keratin
  • 8.5. Lanolin

9. Animal-derived Specialty Ingredients Market, by Animal Source

  • 9.1. Bovine
  • 9.2. Marine
  • 9.3. Porcine
  • 9.4. Poultry

10. Animal-derived Specialty Ingredients Market, by Application

  • 10.1. Animal Feed
  • 10.2. Cosmetics & Personal Care
  • 10.3. Diagnostics
  • 10.4. Food & Beverages
  • 10.5. Nutraceuticals & Supplements
  • 10.6. Pharmaceuticals

11. Animal-derived Specialty Ingredients Market, by Distribution Channel

  • 11.1. Online
  • 11.2. Offline

12. Animal-derived Specialty Ingredients Market, by Form

  • 12.1. Granules
  • 12.2. Liquid
  • 12.3. Powder

13. Animal-derived Specialty Ingredients Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Animal-derived Specialty Ingredients Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Animal-derived Specialty Ingredients Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Animal-derived Specialty Ingredients Market

17. China Animal-derived Specialty Ingredients Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. AMCO Proteins
  • 18.6. Archer Daniels Midland Company
  • 18.7. Arla Foods Ingredients Group P/S
  • 18.8. Associated British Foods PLC
  • 18.9. Cooke Inc.
  • 18.10. Dairy Farmers of America, Inc.
  • 18.11. Darling Ingredients Inc.
  • 18.12. DuPont de Nemours, Inc.
  • 18.13. Fonterra Co-operative Group Limited
  • 18.14. Gelita AG
  • 18.15. Imperial-Oel-Import Handelsgesellschaft mbH
  • 18.16. Kemin Industries, Inc.
  • 18.17. Kerry Group PLC
  • 18.18. Lacto Japan Co., Ltd.
  • 18.19. NCC Food Ingredients
  • 18.20. Novo Holdings A/S
  • 18.21. Oceana Group
  • 18.22. Royal FrieslandCampina N.V.
  • 18.23. Sanimax ABP Inc.
  • 18.24. Tessenderlo Group
  • 18.25. The Kraft Heinz Company
  • 18.26. Nitta Gelatin NA Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY ANIMAL SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY CHONDROITIN SULFATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY CHONDROITIN SULFATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY CHONDROITIN SULFATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY COLLAGEN PEPTIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY COLLAGEN PEPTIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY COLLAGEN PEPTIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY GELATIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY GELATIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY GELATIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY KERATIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY KERATIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY KERATIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY LANOLIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY LANOLIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY LANOLIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY ANIMAL SOURCE, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY BOVINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY BOVINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY BOVINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY MARINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY MARINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY MARINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY PORCINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY PORCINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY PORCINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY POULTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY POULTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY ANIMAL FEED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY ANIMAL FEED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY ANIMAL FEED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY COSMETICS & PERSONAL CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY COSMETICS & PERSONAL CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY COSMETICS & PERSONAL CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY NUTRACEUTICALS & SUPPLEMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY NUTRACEUTICALS & SUPPLEMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY NUTRACEUTICALS & SUPPLEMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY GRANULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY GRANULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY GRANULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY ANIMAL SOURCE, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY ANIMAL SOURCE, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY ANIMAL SOURCE, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY ANIMAL SOURCE, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY ANIMAL SOURCE, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY ANIMAL SOURCE, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 104. AFRICA ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY ANIMAL SOURCE, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY ANIMAL SOURCE, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. ASEAN ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. ASEAN ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. ASEAN ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY ANIMAL SOURCE, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 123. GCC ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GCC ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. GCC ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY ANIMAL SOURCE, 2018-2032 (USD MILLION)
  • TABLE 126. GCC ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. GCC ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. GCC ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPEAN UNION ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPEAN UNION ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPEAN UNION ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY ANIMAL SOURCE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPEAN UNION ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPEAN UNION ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 135. BRICS ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. BRICS ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. BRICS ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY ANIMAL SOURCE, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. BRICS ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. BRICS ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 141. G7 ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. G7 ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. G7 ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY ANIMAL SOURCE, 2018-2032 (USD MILLION)
  • TABLE 144. G7 ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. G7 ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. G7 ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 147. NATO ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. NATO ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. NATO ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY ANIMAL SOURCE, 2018-2032 (USD MILLION)
  • TABLE 150. NATO ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. NATO ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 152. NATO ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. UNITED STATES ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 155. UNITED STATES ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. UNITED STATES ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY ANIMAL SOURCE, 2018-2032 (USD MILLION)
  • TABLE 157. UNITED STATES ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. UNITED STATES ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. UNITED STATES ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 160. CHINA ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 161. CHINA ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. CHINA ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY ANIMAL SOURCE, 2018-2032 (USD MILLION)
  • TABLE 163. CHINA ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. CHINA ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. CHINA ANIMAL-DERIVED SPECIALTY INGREDIENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)